Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio?
Tsen
Lawrence C
LC
Balki
Mrinalini
M
D000328:Adult; D000465:Algorithms; D002585:Cesarean Section; D005260:Female; D006801:Humans; D010120:Oxytocics / Q000009:adverse effects* / Q000627:therapeutic use*; D010121:Oxytocin / Q000009:adverse effects* / Q000627:therapeutic use*; D011247:Pregnancy; D018570:Risk Assessment
D010120:Oxytocics; D010121:Oxytocin